GlassScriptPhysician profile
Steve H Chang
NPI 1801986625
$74,706.80
in general payments reported to CMS, 2019-2025
20 companies · $1,560 in 2025
The $1,560 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32K · 2020: $7,304 · 2021: $8,318 · 2022: $18K · 2023: $5,437 · 2024: $1,816 · 2025: $1,560.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,358 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,430 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,357.54 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,430.00 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $36,719.21 | 2019-2022 | |
| Alcon Vision LLC | $25,427.99 | 2019-2025 | Clareon, Clareon Panoptix Pro, Centurion |
| Rxsight INC | $9,490.76 | 2021-2025 | Rxsight Contact Lens, Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Johnson & Johnson Surgical Vision, INC. | $678.03 | 2019-2025 | Tecnis Iol |
| Eyepoint US, INC. | $618.91 | 2020 | |
| Glaukos Corporation | $534.48 | 2019-2025 | Idose, Idosetr |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $269.49 | 2019-2020 | |
| Rayner Intraocular Lenses Limited | $224.22 | 2022-2024 | Omidria, Rayone Aspheric, Rayone Emv |
| Horizon Therapeutics Plc | $116.58 | 2021 | |
| Bausch Health US, LLC | $102.44 | 2020 | |
| Omeros Corporation | $102.25 | 2019-2021 | |
| Hoffmann-La Roche Limited | $99.00 | 2019 | |
| Sight Sciences, INC. | $93.67 | 2019-2021 | |
| Staar Surgical Company | $77.97 | 2019 | |
| Allergan, INC. | $48.53 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $28.05 | 2024 | Envista Mx60 Iol |
| Biotissue Holdings INC. | $25.00 | 2024 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Kala Pharmaceuticals, INC. | $16.16 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $14.66 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.